Marc Hedrick
Directeur Général chez PLUS THERAPEUTICS, INC.
Fortune : 18 316 $ au 30/06/2024
Profil
Marc H.
Hedrick was the founder of StemSource, Inc. (founded in 2000), where he served as President, Chief Executive Officer & Director from 2001 to 2003.
He is currently the President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2002.
Dr. Hedrick has also held former positions as President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP), Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004, Co-Director at UCLA Anderson School of Management, Director at Cytori Ltd., and Associate Professor at the University of California, Los Angeles.
He holds a doctorate degree from The University of Texas Southwestern Medical Center (1988) and an MBA from UCLA Anderson School of Management (2005).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PLUS THERAPEUTICS, INC.
0,22% | 08/05/2024 | 12 425 ( 0,22% ) | 18 265 $ | 30/06/2024 |
| 25/07/2018 | 35 ( 3,73% ) | 51 $ | 30/06/2024 |
Postes actifs de Marc Hedrick
| Sociétés | Poste | Début |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Directeur Général | 02/04/2014 |
Anciens postes connus de Marc Hedrick
| Sociétés | Poste | Fin |
|---|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Directeur Technique/Scientifique/R&D | 01/01/2004 |
StemSource, Inc.
 StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Fondateur | 01/01/2003 |
| UCLA Anderson School of Management | Corporate Officer/Principal | - |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
 Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Cytori Therapeutics KK engages in the manufacture, import, export and sales of medical devices. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Directeur Général | - |
Formation de Marc Hedrick
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Commercial Services |
Cytori Ltd.
 Cytori Ltd. Pharmaceuticals: OtherHealth Technology Cytori Ltd. develops biological products. The company was founded on February 7, 2014 and is headquartered in Deeside, the United Kingdom. | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Cytori Therapeutics KK engages in the manufacture, import, export and sales of medical devices. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Health Technology |
